• Je něco špatně v tomto záznamu ?

Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry

Z. Šumník, M. Pavlíková, R. Pomahačová, P. Venháčová, L. Petruželková, J. Škvor, D. Neumann, J. Vosáhlo, P. Konečná, J. Čížek, J. Strnadel, Š. Průhová, O. Cinek, ČENDA Project Group

. 2021 ; 22 (3) : 439-447. [pub] 20210217

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012460

OBJECTIVE: Increased access to modern technologies is not always accompanied by a decrease in HbA1c. The aim of this study was to identify changes in the proportion of continuous glucose monitoring (CGM) users since 2017, when general reimbursement for CGM became effective in Czechia, and to test whether HbA1c is associated with the percentage of time spent on CGM. RESEARCH DESIGN AND METHODS: All T1D children in the Czech national ČENDA registry (3197 children) were categorized according to their time spent on CGM and associations with age, sex, center size, and HbA1c were tested with calendar year as a stratification factor. RESULTS: The proportion of children with any CGM use increased from 37.9% in 2017 to 50.3% in 2018 and 74.8% in 2019. Of the CGM users, 16%, 28%, and 41% of the children spent >70% of their time on CGM over the 3 years of the study period, with an overrepresentation of children in the <10 years age group versus the older age groups (p < 0.001). The proportion of CGM users differed among centers and was positively associated with a large center size (>100 patients) (p < 0.001). HbA1c was negatively associated with the time spent on CGM (p < 0.001). CONCLUSIONS: A rapid increase in CGM use was reported over the 3 years after general reimbursement. HbA1c was associated with time spent on CGM, a continuing decrease was observed in the >70% category. Reimbursement for CGM likely contributes to the improvement of T1D control at the population level.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012460
003      
CZ-PrNML
005      
20220506131057.0
007      
ta
008      
220425s2021 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/pedi.13184 $2 doi
035    __
$a (PubMed)33533545
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Šumník, Zdeněk $u Department of Pediatrics, Motol University Hospital and Charles University, 2nd Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000264626462 $7 xx0036973
245    10
$a Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry / $c Z. Šumník, M. Pavlíková, R. Pomahačová, P. Venháčová, L. Petruželková, J. Škvor, D. Neumann, J. Vosáhlo, P. Konečná, J. Čížek, J. Strnadel, Š. Průhová, O. Cinek, ČENDA Project Group
520    9_
$a OBJECTIVE: Increased access to modern technologies is not always accompanied by a decrease in HbA1c. The aim of this study was to identify changes in the proportion of continuous glucose monitoring (CGM) users since 2017, when general reimbursement for CGM became effective in Czechia, and to test whether HbA1c is associated with the percentage of time spent on CGM. RESEARCH DESIGN AND ME $a OBJECTIVE Increased access to modern technologies is not always accompanied by a decrease in HbA1c The aim of this study was to identify changes in the proportion of continuous glucose monitoring CGM users since 2017 when general reimbursement for CGM became effective in Czechia and to test whether HbA1c is associated with the percentage of time spent on CGM RESEARCH DESIGN AND METHODS A $a OBJECTIVE: Increased access to modern technologies is not always accompanied by a decrease in HbA1c. The aim of this study was to identify changes in the proportion of continuous glucose monitoring (CGM) users since 2017, when general reimbursement for CGM became effective in Czechia, and to test whether HbA1c is associated with the percentage of time spent on CGM. RESEARCH DESIGN AND METHODS: All T1D children in the Czech national ČENDA registry (3197 children) were categorized according to their time spent on CGM and associations with age, sex, center size, and HbA1c were tested with calendar year as a stratification factor. RESULTS: The proportion of children with any CGM use increased from 37.9% in 2017 to 50.3% in 2018 and 74.8% in 2019. Of the CGM users, 16%, 28%, and 41% of the children spent >70% of their time on CGM over the 3 years of the study period, with an overrepresentation of children in the <10 years age group versus the older age groups (p < 0.001). The proportion of CGM users differed among centers and was positively associated with a large center size (>100 patients) (p < 0.001). HbA1c was negatively associated with the time spent on CGM (p < 0.001). CONCLUSIONS: A rapid increase in CGM use was reported over the 3 years after general reimbursement. HbA1c was associated with time spent on CGM, a continuing decrease was observed in the >70% category. Reimbursement for CGM likely contributes to the improvement of T1D control at the population level.
650    _2
$a mladiství $7 D000293
650    _2
$a věkové faktory $7 D000367
650    12
$a selfmonitoring glykemie $7 D015190
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a diabetes mellitus 1. typu $x krev $x farmakoterapie $7 D003922
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glykovaný hemoglobin $x metabolismus $7 D006442
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x terapeutické užití $7 D007004
650    _2
$a kojenec $7 D007223
650    _2
$a inzulin $x terapeutické užití $7 D007328
650    _2
$a úhrada zdravotního pojištění $7 D007349
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a registrace $7 D012042
650    _2
$a sexuální faktory $7 D012737
650    _2
$a časové faktory $7 D013997
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pavlíková, Markéta $u Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
700    1_
$a Pomahačová, Renata $u Department of Pediatrics, University Hospital Pilsen, Pilsen, Czech Republic
700    1_
$a Venháčová, Petra $u Department of Pediatrics, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Petruželková, Lenka $u Department of Pediatrics, Motol University Hospital and Charles University, 2nd Faculty of Medicine, Prague, Czech Republic
700    1_
$a Škvor, Jaroslav $u Department of Pediatrics, Masaryk Hospital, Ústí nad Labem, Czech Republic
700    1_
$a Neumann, David $u Department of Pediatrics, University Hospital, Hradec Králové, Czech Republic
700    1_
$a Vosáhlo, Jan $u Department of Pediatrics, 3rd Faculty of Medicine, Prague, Czech Republic
700    1_
$a Konečná, Petra $u Department of Pediatrics, University Hospital Brno, Brno, Czech Republic
700    1_
$a Čížek, Jindřich $u Department of Pediatrics, Hospital České Budějovice, České Budějovice, Czech Republic
700    1_
$a Strnadel, Jiří $u Department of Pediatrics, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Průhová, Štěpánka $u Department of Pediatrics, Motol University Hospital and Charles University, 2nd Faculty of Medicine, Prague, Czech Republic
700    1_
$a Cinek, Ondřej $u Department of Pediatrics, Motol University Hospital and Charles University, 2nd Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000205268714 $7 nlk20050167617
710    2_
$a ČENDA Project Group
773    0_
$w MED00181048 $t Pediatric diabetes $x 1399-5448 $g Roč. 22, č. 3 (2021), s. 439-447
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33533545 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131049 $b ABA008
999    __
$a ok $b bmc $g 1789877 $s 1163661
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 3 $d 439-447 $e 20210217 $i 1399-5448 $m Pediatric diabetes $n Pediatr Diabetes $x MED00181048
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

    Možnosti archivace